The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy
- PMID: 15193690
- DOI: 10.1016/j.jacc.2004.03.035
The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy
Abstract
Objectives: We sought to identify the histologic basis of myocardial late gadolinium enhancement cardiovascular magnetic resonance (CMR) in hypertrophic cardiomyopathy (HCM).
Background: The histologic basis of late gadolinium CMR in patients with HCM is unknown.
Methods: A 28-year-old male patient with HCM and heart failure underwent late gadolinium enhancement CMR and, 49 days later, heart transplantation. The explanted heart was examined histologically for the extent of collagen and disarray, and the results were compared with a previous in vivo CMR scan.
Results: Overall, 19% of the myocardium was collagen, but the amount per segment varied widely (SD +/- 19, range 0% to 71%). Both disarray and collagen were more likely to be found in the mesocardium than in the endo- or epicardium. There was a significant relationship between the extent of late gadolinium enhancement and collagen (r = 0.7, p < 0.0001) but not myocardial disarray (p = 0.58). Segments containing >15% collagen were more likely to have late gadolinium enhancement. Regional wall motion was inversely related to the extent of myocardial collagen and late gadolinium enhancement but not disarray (p = 0.0003, 0.04, and NS, respectively).
Conclusions: In this patient with HCM and heart failure, regions of myocardial late gadolinium enhancement by CMR represented regions of increased myocardial collagen but not disarray.
Similar articles
-
[Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].Rev Esp Cardiol. 2007 Jan;60(1):15-23. Rev Esp Cardiol. 2007. PMID: 17288951 Spanish.
-
Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.Arch Cardiovasc Dis. 2015 Jun-Jul;108(6-7):356-66. doi: 10.1016/j.acvd.2015.01.010. Epub 2015 Apr 8. Arch Cardiovasc Dis. 2015. PMID: 25863428 Clinical Trial.
-
Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.J Cardiovasc Magn Reson. 2012 Oct 29;14(1):76. doi: 10.1186/1532-429X-14-76. J Cardiovasc Magn Reson. 2012. PMID: 23107451 Free PMC article.
-
Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy.Int J Cardiovasc Imaging. 2020 Jun;36(6):1147-1156. doi: 10.1007/s10554-020-01808-6. Epub 2020 Mar 12. Int J Cardiovasc Imaging. 2020. PMID: 32166506 Review.
-
Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.Cardiol J. 2016;23(3):250-63. doi: 10.5603/CJ.a2016.0019. Epub 2016 Apr 11. Cardiol J. 2016. PMID: 27064795 Review.
Cited by
-
Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy.Eur Heart J Cardiovasc Imaging. 2022 Mar 22;23(4):532-542. doi: 10.1093/ehjci/jeab056. Eur Heart J Cardiovasc Imaging. 2022. PMID: 33779725 Free PMC article.
-
Cardiovascular Magnetic Resonance for the Differentiation of Left Ventricular Hypertrophy.Curr Heart Fail Rep. 2020 Oct;17(5):192-204. doi: 10.1007/s11897-020-00481-z. Curr Heart Fail Rep. 2020. PMID: 32844347 Free PMC article. Review.
-
A primer on arrhythmias in patients with hypertrophic cardiomyopathy.Curr Cardiol Rep. 2012 Oct;14(5):552-62. doi: 10.1007/s11886-012-0297-3. Curr Cardiol Rep. 2012. PMID: 22825919 Review.
-
Editorial. Hypertrophic Cardiomyopathy with ventricular tachycardia.Int J Cardiovasc Imaging. 2008 Jan;24(1):85-7. doi: 10.1007/s10554-007-9234-8. Epub 2007 Jun 1. Int J Cardiovasc Imaging. 2008. PMID: 17541762 No abstract available.
-
Use of cardiovascular magnetic resonance for diagnosis and management in hypertrophic cardiomyopathy.Curr Cardiol Rep. 2007 Mar;9(1):51-6. doi: 10.1007/s11886-007-0010-0. Curr Cardiol Rep. 2007. PMID: 17362685 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous